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Introduction {#sec1}
============

Somatic cells can be reprogrammed to pluripotency through the ectopic expression of defined factors such as Oct4, Sox2, Klf4, and c-Myc ([@bib33], [@bib32]). The resultant induced pluripotent stem cells (iPSCs) provide unlimited cell sources in studying disease and in regenerative medicine ([@bib41]). Pigs show many similarities to humans in organ anatomy, physiology, and metabolism ([@bib38]) and could be a suitable source of xenotransplantation and a model for the study of human diseases ([@bib11]). Derivation of pig iPSCs can complement research on human iPSCs ([@bib23]). With fewer ethical concerns, robust transplantation experiments using pigs as a model could test the safety and effectiveness of iPSCs in pre-clinical translational medicine, such as retinal ([@bib42]) and myocardial therapy ([@bib19]).

Currently, the main obstacle in achieving fully reprogrammed porcine iPSCs (piPSCs) is inadequate silencing of exogenous genes ([@bib7], [@bib8], [@bib9], [@bib24], [@bib40]), even after using non-integrating episomal plasmids ([@bib6]) or Sendai virus ([@bib5]).

Epigenetic modification by active DNA demethylation or histone demethylation has been shown to facilitate iPSC induction in human and mouse ([@bib13], [@bib14]). Tet1, a DNA methylcytosine dioxygenase, can facilitate iPSC induction by promoting *Oct4* demethylation and re-activation, and even can replace Oct4 to initiate somatic cell reprogramming ([@bib10]). H3K9me3 acts as a block to pluripotency, and Kdm3a/Jmjd1a as a histone H3K9 demethylase, or vitamin C that also can demethylate the histones, enhances reprogramming ([@bib4], [@bib21]). Tet3 is another dioxygenase of Tet enzymes, and Tet3-mediated DNA hydroxylation is involved in epigenetic reprogramming of the zygotic paternal DNA ([@bib12]); however, it has not been determined whether Tet3 can facilitate iPSC generation.

Recently, a new pluripotent state, called "F-class iPSCs" was found ([@bib15], [@bib35]). The F-class iPSCs is at a Nanog-positive cell state that is stable, occurs frequently, and is dependent on high expression of reprogramming factors, and these cells do not form typical embryonic stem cell (ESC)-like colonies. The F-class cells express significantly reduced levels of many PluriNet genes ([@bib25]), including *Dnmt3b*, *Rex1* (*Zfp42*), and *Tdgf1* (*Cripto*). Nevertheless, they also express many genes at ESC levels such as *Sall4*, endogenous *Oct4*, and *Nanog*. After treatment with histone deacetylase inhibitors (HDACi), sodium butyrate (NaB), or trichostatin A (TSA), these cells could be converted to transgene-independent ESC-like cells capable of contributing to chimeras and the germline ([@bib35]). We speculated that piPSCs might resemble F-class iPSCs to some extent given that the exogenous genes of piPSCs are not silenced, the edges of early piPSCs appear fuzzy, and piPSCs express relatively high levels of endogenous *Oct4* and *Nanog*, but low level of *Rex1* as one of important naive state marker genes (as seen below).

We tested whether epigenetic factors, including Tet3, Tet1, and Kdm3a, or small molecules that increase histone acetylation, could enhance epigenetic reprogramming and silencing of the exogenous genes in piPSCs.

Results {#sec2}
=======

Epigenetic Regulatory Factors Activate *Rex1* {#sec2.1}
---------------------------------------------

*Rex1* is a naive pluripotent state marker ([@bib26]), and its expression has been positively linked to increased pluripotency in both mouse ([@bib27], [@bib36]) and human ESCs and iPSCs ([@bib2], [@bib3]). *Rex1* also is expressed in the inner cell mass of blastocyst and in trophectoderm cells or trophoblast-derived tissues during mouse and porcine embryo development ([@bib20], [@bib30]). Under certain conditions, piPSCs acquire features of naive pluripotency, characterized by expression of *Rex1* and *Stella* ([@bib29]). However, pig epiblast stem cell lines (pEpiSC) do not express *Rex1* ([@bib1]). We also found that piPSCs expressing *Rex1* (Rex1^+^) showed higher expression levels of many genes associated with pluripotency, including *E-cadherin*, *Utf1*, *Dppa2*, *Cripto*, *Eras*, *Cdc20*, *Nr6a1*, *Tert*, and *Terc*, compared with piPSCs with minimal *Rex1* (Rex1^−^) ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Moreover, Rex1^+^ piPSCs also expressed high levels of genes related to pluripotency regulation network in association with *Rex1* ([@bib39]), such as *Nac1*, *Wdr18*, *Prmt1*, *Cdk1*, and *Arid3a* ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Together, high expression levels of *Rex1* can mark high pluripotency of piPSC lines.

To activate *Rex1* and to promote the silence of exogenous genes of piPSCs, we overexpressed epigenetic regulatory factors, including *Tet1*, mouse *Tet3* (*mTet3*) available, or *Kdm3a*, together with OSKM (4F) to generate piPSCs from porcine embryonic fibroblasts (PEF) as precursor cells. To achieve mouse ESC/iPSC-like colonies, we employed the conditions for mouse iPSC induction by adding human leukemia inhibitory factor but without basic fibroblast growth factor, and with NaB ([@bib43]), S-adenosylhomocysteine ([@bib16]), and BIX01294 ([@bib31]). These small molecules are known to enhance induction and quality of mouse and human iPSCs.

To confirm the presence of the introduced epigenetic regulatory factors, cells were tested on day 9 of reprogramming for the expression of epigenetic factors. As expected, PEF infected by OSKM together with epigenetic factors expressed high levels of the corresponding factors ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Moreover, *Rex1* was consistently elevated in the piPSC lines induced by 4F + Tet1, and variably activated in piPSC clones generated by addition of other epigenetic regulation factors ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2E). Expression levels of *Rex1* positively correlated with those of exogenous epigenetic regulatory factors ([Figures S2](#mmc1){ref-type="supplementary-material"}B--S2E).

piPSCs were successfully generated from OSKM (4F, control), 4F + mTet3, 4F + Tet1, 4F + Kdm3a, and 4F + Tet1+Kdm3a. piPSC colonies derived by OSKM with epigenetic factors appeared as round and dome-shaped in contrast to the flattened shape formed by OSKM alone by day 15 ([Figure S1](#mmc1){ref-type="supplementary-material"}C). piPSC clones induced by OSKM were loosened and their boundaries were fuzzy while piPSC clones induced by OSKM with epigenetic factors were compact with visible boundaries ([Figure S1](#mmc1){ref-type="supplementary-material"}C). By randomly picking up a number of colonies, we obtained piPSC clones that resembled typical mouse ESCs in morphology, characterized by dome-shaped compact colonies with large nuclei and clear nucleoli in the cells, distinct from feeder fibroblasts ([Figure 1](#fig1){ref-type="fig"}A). Based on relatively high expression levels of *Rex1*, we further characterized the pluripotency of numerous piPSC lines, including two 4F + mTet3, two 4F + Tet1, one 4F + Kdm3a, and two 4F + Tet1+Kdm3a.

piPSCs Induced by Epigenetic Regulatory Factors Express High Levels of Genes Associated with Pluripotency {#sec2.2}
---------------------------------------------------------------------------------------------------------

RT-qPCR analysis revealed that expression levels of endogenous *Oct4* and *Nanog* in piPSCs were much higher than those of PEF ([Figure 1](#fig1){ref-type="fig"}B, left). Expression levels of *endo*-*Oct4* were also higher in piPSC lines induced by OSKM with Tet1 ([Figure 1](#fig1){ref-type="fig"}B, left), consistent with the report that *Tet1* can activate *Oct4* ([@bib10]), while *endo-Oct4* expression levels in piPSC lines induced by other epigenetic factors were similar to those of OSKM controls ([Figure 1](#fig1){ref-type="fig"}B, left). Expression levels of *Nanog* did not differ among piPSC lines induced by OSKM with epigenetic factors ([Figure 1](#fig1){ref-type="fig"}B, left). In addition, *endo-Sox2* and *endo-Klf4* were also activated and expression of *endo-cMyc* reduced to some extent in piPSCs ([Figure 1](#fig1){ref-type="fig"}B, middle).

Furthermore, piPSC lines expressed higher levels of *Rex1* induced by epigenetic factors, compared with 4F control ([Figure 1](#fig1){ref-type="fig"}B, left). Tet1 and Tet1+Kdm3a appeared to be more effective in activating *Rex1* ([Figure 1](#fig1){ref-type="fig"}B, left). Notably, immunofluorescence microscopy showed *trans*-localization of Rex1 from the cytoplasm in piPSCs induced by 4F control to the nuclei in piPSCs derived by addition of epigenetic factors ([Figure 2](#fig2){ref-type="fig"}A). The nuclear localization of Rex1 may suggest its function in these piPSCs. Western blotting also revealed variable expression levels of Rex1 protein in piPSC lines induced by 4F control and addition of epigenetic factors ([Figure S3](#mmc1){ref-type="supplementary-material"}A).

In addition, piPSCs induced by OSKM with epigenetic factors expressed higher levels of other genes important for naive state, such as *Utf1, Dppa2*, and *Esrrb* ([@bib37]) ([Figure 1](#fig1){ref-type="fig"}B, right), relative to piPSCs induced by OSKM alone. All three epigenetic factors were able to activate *Utf1* and *Dppa2*, while mTet3, Tet1, and Tet1+Kdm3a significantly activated *Esrrb*, compared with 4F-piPSCs. Higher expression levels of *Rex1*, *Utf1*, *Dppa2*, and *Esrrb* in piPSCs generated by additional epigenetic modifiers suggest their pluripotency toward naive state.

The exogenous epigenetic factors were able to activate their corresponding endogenous genes. Expression levels of *endo-Tet1* were much higher in piPSCs induced by OSKM in combination with Tet1 or Tet1+Kdm3a ([Figure 1](#fig1){ref-type="fig"}D). Expression levels of *Tet2* were also higher in piPSCs induced by epigenetic factors except for two 4F + Tet1 piPSC lines ([Figure 1](#fig1){ref-type="fig"}D). Expression levels of *Tet3* in 4F + mTet3 and 4F + Tet1+Kdm3a piPSC lines and of *endo-Kdm3a* in 4F + Kdm3a and 4F + Tet1+Kdm3a piPSC lines also were higher than those of controls ([Figure 1](#fig1){ref-type="fig"}D). Furthermore, these piPSCs expressed multiple pluripotent stem cell markers revealed by immunofluorescence, including Oct4, Nanog, and Sox2 in the nuclei and SSEA-1 on cell surface ([Figures 2](#fig2){ref-type="fig"}B and 2C).

By western blot, H3K9me3 protein levels declined in mTet3, Tet1, and Kdm3a-derived piPSCs, while H3K27me3 declined only in Tet1-derived piPSCs ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Unexpectedly, combination of Tet1 and Kdm3a did not reduce the protein levels of H3K9me3 and H3K27me3 ([Figure S3](#mmc1){ref-type="supplementary-material"}A). These results suggest that different epigenetic factors further open chromatin to induce activation of pluripotency genes, although they may affect histone modifications differently.

Importantly, most piPSCs maintained normal karyotypes ([Figure S3](#mmc1){ref-type="supplementary-material"}B) and can be propagated by single cells using TrypLE for more than 30 passages. Furthermore, the piPSCs derived by epigenetic factors showed transgene copy numbers at slightly higher but comparable levels with 4F control ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Thus, high expression levels of endogenous pluripotency genes in piPSCs induced by epigenetic factors are not likely due to differences in infection efficiency or transgene integration, but to the roles of these epigenetic factors in induction of piPSCs.

Various Expression Levels of Exogenous Genes in piPSCs {#sec2.3}
------------------------------------------------------

Exogenous *mTet3* was exclusively expressed in piPSCs induced by 4F + mTet3, *ex-Tet1* in piPSCs by 4F + Tet1 or 4F + Tet1+Kdm3a, and *ex-Kdm3a* in piPSCs by 4F + Kdm3a or 4F + Tet1+Kdm3a ([Figure 1](#fig1){ref-type="fig"}C). Exogenous transcription factor genes were either unchanged or upregulated in most of the piPSC lines regardless of addition of epigenetic factors, compared with those of OSKM at day 9 of induction ([Figure 1](#fig1){ref-type="fig"}E). Higher expression of *ex-cMyc* may compensate for the low expression levels of *endo-cMyc*. Together, exogenous genes were not effectively silenced in most of piPSCs induced by epigenetic factors, especially in Kdm3a-derived piPSCs ([Figure 1](#fig1){ref-type="fig"}E). Thus, while epigenetic factors can enhance reprogramming and activation of naive pluripotency genes in piPSCs, their effects on silencing exogenous genes are variable.

Pluripotency of piPSCs by Teratoma Test {#sec2.4}
---------------------------------------

To examine the developmental potential of piPSCs generated by epigenetic regulation factors, we performed an in vivo differentiation test by teratoma formation ([@bib18], [@bib22]). piPSCs induced by 4F, 4F + Tet1, and 4F + mTet3 formed teratomas following subcutaneous transplantation into non-obese diabetic/severe combined immunodeficiency mice, whereas 4F + Kdm3a and 4F + Tet1 + Kdm3a did not ([Figure 3](#fig3){ref-type="fig"}A). The 4F + Tet1-piPSCs formed teratomas faster and larger than did 4F- or 4F + mTet3-piPSCs ([Figures 3](#fig3){ref-type="fig"}A and 3B). In addition to the delayed formation, teratomas from 4F + mTet3-piPSCs were even smaller than those of OSKM ([Figures 3](#fig3){ref-type="fig"}A and 3B). The teratomas formed from these piPSCs showed the characteristic three embryonic germ layers, including neural epithelium (ectoderm), muscle (mesoderm), and gland epithelium (endoderm) ([Figure 3](#fig3){ref-type="fig"}A). Immunofluorescence microscopy validated that these teratomas expressed markers representative of three germ layers, including nestin (ectoderm), smooth muscle actin (mesoderm), and alpha 1-fetoprotein (endoderm) ([Figure 3](#fig3){ref-type="fig"}C), consistent with the results by immunohistochemistry ([Figure S3](#mmc1){ref-type="supplementary-material"}D). Notably, piPSCs induced by Tet1 combined with OSKM exhibited enhanced differentiation capacity, while mTet3 seemed to reduce the differentiation potential of piPSCs ([Figures 3](#fig3){ref-type="fig"}A--3C).

Conversion of piPSCs by HDACi {#sec2.5}
-----------------------------

piPSCs failed from silencing of exogenous genes presumably are similar to the F-class iPSCs described recently, which, however, can be converted to naive iPSCs by HDACi ([@bib35]). To further reduce expression of exogenous genes and achieve the naive state, we attempted to convert two relatively high-quality piPSC lines, induced by epigenetic factors shown above (4F + Tet1 and 4F + Kdm3a), by adding HDACi, NaB, TSA, or valproic acid (VPA). Following culture in HDACi for three passages, piPSCs induced from 4F + Tet1 or 4F + Kdm3a maintained their original morphology ([Figures 4](#fig4){ref-type="fig"}A and 4C). With regard to the expression of exogenous genes, expression of *ex-Oct4* was maintained in piPSCs induced by 4F + Tet1 after six passages by treatment with NaB or VPA but significantly declined after three and six passages by exposure to TSA ([Figure 4](#fig4){ref-type="fig"}B). Expression levels of *ex-Sox2* remained unchanged after exposure to TSA or VPA ([Figure 4](#fig4){ref-type="fig"}B). piPSCs induced from 4F + Kdm3a showed lower expression of exogenous genes with increasing passages ([Figure 4](#fig4){ref-type="fig"}D). Expression levels of both *ex-Oct4* and *ex-Sox2* in 4F + Kdm3a were noticeably reduced after six passages in the presence of TSA or VPA, compared with controls ([Figure 4](#fig4){ref-type="fig"}D). Thus, exogenous genes were downregulated by HDACi.

HDACi Increases Expression of Pluripotency Genes in piPSCs {#sec2.6}
----------------------------------------------------------

In piPSCs induced from 4F + Tet1, *endo-Oct4* was upregulated but *Tert* expression minimally affected in the presence of HDACi. NaB significantly upregulated *endo-Oct4*, *Nanog*, *Rex1*, and *E-cadherin* ([Figure 4](#fig4){ref-type="fig"}B). Similarly, piPSCs induced from 4F + Kdm3a exhibited further increased expression levels of genes related to naive pluripotency following HDACi treatment. Both *endo-Oct4* and *endo-Nanog* were upregulated ([Figure 4](#fig4){ref-type="fig"}D) and expression levels of *Tert* and *Terc* were maintained by HDACi ([Figure 4](#fig4){ref-type="fig"}D). *Rex1* and *E-cadherin* also were upregulated by NaB ([Figure 4](#fig4){ref-type="fig"}D).

We also tested effects of 5-azacytidine and vitamin C on conversion of piPSCs. Consistent with a recent finding ([@bib35]), these two small molecules did not silence exogenous genes in piPSCs ([Figure S4](#mmc1){ref-type="supplementary-material"}).

Discussion {#sec3}
==========

We show that epigenetic regulatory factors can enhance reprogramming of piPSCs and addition of HDACi can further downregulate exogenous genes. Consistent with the notion that *Rex1* is an indicator of the naive pluripotent state ([@bib26]), piPSCs induced by epigenetic factors, especially Tet1, show significantly activated *Rex1* and other genes important for naive state, including *Utf1, Esrrb*, and *Dppa2*.

piPSCs are maintained dependent on exogenous genes, more like the "F-class" iPSCs ([@bib15], [@bib35]). By exposure to HDACi, the two selected piPSC lines (4F + Tet1 and 4F + Kdm3a) show reduced expression of exogenous genes, especially in 4F + Kdm3a, and increased expression of endogenous genes associated with pluripotency. It is possible to convert F-class to naive-like state in some piPSCs. piPSCs in the presence of HDACi, including NaB, VPA, and suberoylanilide hydroxamic acid, express higher levels of *Oct4*, *Nanog*, *Utf1*, *Rex1*, *Epcam*, and *Esrrb*, compared with control ([@bib28]), confirmed in our study. VPA has been used for conversion of piPSCs from primed to naive-like state ([@bib34]). Moreover, we find that HDACi can moderately reduce expression of exogenous genes in piPSCs and increase expression of genes associated with pluripotency. Although exogenous genes are not effectively silenced, these approaches provide the basis for optimizing derivation and culture of piPSCs.

Despite the fact that epigenetic modifiers facilitate reprogramming and reduce reliance on exogenous genes, exogenous genes are still required to maintain pluripotency of piPSCs, likely suggesting that activation of endogenous genes is inadequate to maintain pluripotency of piPSCs, such that continued expression of exogenous genes complements the deficiency. It is also possible that some key pluripotency regulators in pigs may differ from the conventional reprogramming mixture. It is anticipated that methods that can fully activate endogenous pluripotent genes would allow piPSCs to self-renew without reliance on exogenous genes. Development of naive porcine ESCs and appropriate culture conditions become more critical for comparison of expression levels of endogenous pluripotent genes.

Experimental Procedures {#sec4}
=======================

Mice Used for Teratoma Tests {#sec4.1}
----------------------------

The care and use of mice for this research followed the guidelines and protocols for animal research approved by the Institutional Animal Care and Use Committee of Nankai University.

Generation of piPSCs {#sec4.2}
--------------------

Retroviruses were produced and harvested following the protocol described previously ([@bib17]).

For the induction of piPSCs, 1 × 10^5^ PEF at passage 1--2 were plated in a 6-well dish prior to infection. Cells were infected with corresponding pMXs-based retroviral vectors (Oct4, Sox2, Klf4, c-Myc, mTet3, Tet1, and Kdm3a, 100 μL of concentrated virus suspension for each factor) for 12 hr twice with a 24-hr interval. Cells were induced to iPSCs in induction medium, and the medium changed daily. About 9 days after infection, 5 × 10^4^ cells were passaged on to mitomycin C-inactivated mouse embryonic fibroblast (MEF) feeder cells in a 60-mm dish. ESC-like colonies were picked at days 18--20 following a standard protocol. See also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Cell Culture {#sec4.3}
------------

The piPSCs were maintained on MEF treated with mitomycin C and cultured in piPSCs culture medium. piPSCs were passaged using TrypLE at a ratio of 1:10 every 3--4 days. See also [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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![Generation and Characterization of piPSCs Induced by OSKM or OSKM in Combination with Epigenetic Regulatory Factors\
(A) Representative images showing piPSCs induced by various conditions. Scale bar, 100 μm.\
(B) RT-qPCR analysis of endogenous pluripotent genes. Left and middle, ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, compared with PEF. Right, ^∗/\#^p \< 0.05, ^∗∗/\#\#^p \< 0.01, ^∗∗∗/\#\#\#^p \< 0.001, compared with control (4F) piPSC lines. Mouse ESCs (N33) served as positive control.\
(C and D) RT-qPCR analysis of exogenous (C) and endogenous (D) epigenetic regulatory genes. p values as in (B).\
(E) RT-qPCR analysis of exogenous genes. OSKM at day 9 (OSKM D9) served as positive control for exogenous genes. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, compared with OSKM D9. Data represent mean ± SEM from three independent experiments. ns, not significant.\
See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![Characterization of piPSCs by Immunofluorescence Microscopy\
(A) Translocation of Rex1 from cytoplasm to nuclei in piPSCs induced by epigenetic factors.\
(B) piPSCs induced by leukemia inhibitory factor without basic fibroblast growth factor express SSEA-1.\
(C) Expression of pluripotent marker genes, Oct4, Nanog, and Sox2 in nuclei of piPSCs. Scale bars, 10 μm (A) or 20 μm (B) and (C). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![Differentiation Potential of piPSCs Induced by Addition of Epigenetic Factors\
(A) Left, differentiation in vivo of piPSCs by teratoma formation test following injection into non-obese diabetic/severe combined immunodeficiency mice. Right, H&E staining of teratoma tissues derived from piPSCs. ^∗^, neural epithelium (ectoderm), ^∗∗^, muscle (mesoderm), ^∗∗∗^, gland epithelium (endoderm).\
(B) Weight and time of teratomas formed from piPSCs.\
(C) Immunofluorescence of the teratomas showing markers representative of three germ layers, nestin (ectoderm), smooth muscle actin (SMA, mesoderm), and alpha 1-fetoprotein (AFP, endoderm). Scale bars, 100 μm (A) or 50 μm (C). See also [Figure S3](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Conversion of piPSCs by HDACi\
(A and C) Representative microscopy images showing morphology of piPSCs induced by 4F + Tet1 (A) or 4F + Kdm3a (C) after HDACi treatment for three passages, compared with control without HDACi. Scale bar, 100 μm.\
(B and D) RT-qPCR analysis of selected exogenous genes and pluripotency genes of 4F + Tet1 (B) or 4F + Kdm3a (D). P, passaging number after exposure to HDACi. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ns, not significant, compared with control. Data represent mean ± SEM from three independent experiments.\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}
